Abstract
Over the course of the past several decades treatment of peripheral arterial disease (PAD) has changed in North America. Advent of new technology has led to a shift in the initial treatment of both intermittent claudication (IC) and critical limb ischemia (CLI) towards endovascular intervention—including percutaneous balloon angioplasty, stenting and atherectomy. Overall increase in interventions for PAD correlates with a surge in the number of endovascular procedures performed by interventional cardiologists, interventional radiologists and vascular surgeons. Changes in reimbursement patterns has led to a trend towards these procedures being performed in an outpatient or office setting. Although this has resulted in fewer cases being performed in the hospital potential cost saving has been offset by increased use of the more highly reimbursed atherectomy in the outpatient setting. With regard to recommendations on how to treat these patients the Society of Vascular Surgery (SVS) has recently published guidelines for the treatment of IC emphasizing the importance of initial conservative medical management. There continues to be significant equipoise in the treatment of CLI across North America leading to tremendous variability in the use of open surgery and endovascular therapy. Guidance for the future treatment of CLI is partially dependent upon the Best Endovascular versus Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial, a randomized, controlled trial currently accruing patients in North America.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goodney PP, Tarulli M, Faerber AE, Schanzer A, Zwolak RM. Fifteen-year trends in lower limb amputation, revascularization, and preventive measures among medicare patients. JAMA Surg. 2015;150(1):84–6.
Siracuse JJ, Giles KA, Pomposelli FB, Hamdan AD, Wyers MC, Chaikof EL, Nedeau AE, Schermerhorn ML. Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease. J Vasc Surg. 2012;55(4):1001–7.
Siracuse JJ, Gill HL, Cassidy SP, Messina MD, Catz D, Egorova N, Parrack I, McKinsey JF. Endovascular treatment of lesions in the below-knee popliteal artery. J Vasc Surg. 2014;60(2):356–61.
Gallagher KA, Meltzer AJ, Ravin RA, Graham A, Shrikhande G, Connolly PH, Aiello F, Dayal R, McKinsey JF. Endovascular management as first therapy for chronic total occlusion of the lower extremity arteries: comparison of balloon angioplasty, stenting, and directional atherectomy. J Endovasc Ther. 2011;18(5):624–37.
Sachs T, Pomposelli F, Hamdan A, Wyers M, Schermerhorn M. Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft. J Vasc Surg. 2011;54(4):1021–31.
Goodney PP, Travis LL, Brooke BS, DeMartino RR, Goodman DC, Fisher ES, Birkmeyer JD. Relationship between regional spending on vascular care and amputation rate. JAMA Surg. 2014;149(1):34–42.
Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50:54.
Assi R, Dardik A. Endovascular training of vascular surgeons in the USA. Ann Vasc Dis. 2012;5(4):423–7.
Vogel TR, Dombrovskiy VY, Carson JL, Haser PB, Graham AM. Lower extremity angioplasty: impact of practitioner specialty and volume on practice patterns and healthcare resource utilization. J Vasc Surg. 2009;50(6):1320–4.
Jones WS, Mi X, Qualls LG, Vemulapalli S, Peterson ED, Patel MR, Curtis LH. Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system. J Am Coll Cardiol. 2015;65(9):920–7.
Jain KM, Munn J, Rummel M, Vaddineni S, Longton C. Future of vascular surgery is in the office. J Vasc Surg. 2010;51:509–13.
Egorova NN, Guillerme S, Gelijns A, Morrissey N, Dayal R, McKinsey JF, Nowygrod R. An analysis of the outcomes of a decade of experience with lower extremity revascularization including limb salvage, lengths of stay, and safety. J Vasc Surg. 2010;51(4):878–85. 885.
Society for Vascular Surgery Lower Extremity Guidelines Writing Group, Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, Moneta GL, Murad MH, Powell RJ, Reed AB, Schanzer A, Sidawy AN, Society for Vascular Surgery. Society for vascular surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015;61 Suppl 3:2S–41S.
Farber A, Rosenfield K, Menard M. The BEST-CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia. Tech Vasc Interv Radiol. 2014;17(3):221–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Siracuse, J.J., Farber, A. (2017). Vascular Surgery in North America: Current Perspectives in Peripheral Arterial Disease. In: Dardik, A. (eds) Vascular Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-33745-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-33745-6_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33743-2
Online ISBN: 978-3-319-33745-6
eBook Packages: MedicineMedicine (R0)